{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:12:13Z","timestamp":1790712733113,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s11764-015-0463-x","type":"journal-article","created":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T07:30:40Z","timestamp":1435649440000},"page":"176-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5\u00a0years following adjuvant chemotherapy"],"prefix":"10.1007","volume":"10","author":[{"given":"J. A.","family":"Lawrence","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. P.","family":"Balcueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. L.","family":"Groteluschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. A.","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. J.","family":"Lesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Naughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. D.","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. G.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R.","family":"Rapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,1]]},"reference":[{"issue":"4","key":"463_CR1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1158\/1055-9965.EPI-12-1356","volume":"22","author":"JS Moor de","year":"2013","unstructured":"de Moor JS et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev. 2013;22(4):561\u201370.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"463_CR2","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/13803390490510905","volume":"26","author":"SA Castellon","year":"2004","unstructured":"Castellon SA et al. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol. 2004;26(7):955\u201369.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"2","key":"463_CR3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.20.2.485","volume":"20","author":"TA Ahles","year":"2002","unstructured":"Ahles TA et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol. 2002;20(2):485\u201393.","journal-title":"J Clin Oncol"},{"issue":"1","key":"463_CR4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3816\/CBC.2008.n.006","volume":"8","author":"BP Kreukels","year":"2008","unstructured":"Kreukels BP et al. Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer. Clin Breast Cancer. 2008;8(1):80\u20137.","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"463_CR5","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G","volume":"85","author":"SB Schagen","year":"1999","unstructured":"Schagen SB et al. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer. 1999;85(3):640\u201350.","journal-title":"Cancer"},{"issue":"11","key":"463_CR6","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1002\/cncr.20272","volume":"100","author":"JS Wefel","year":"2004","unstructured":"Wefel JS et al. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer. 2004;100(11):2292\u20139.","journal-title":"Cancer"},{"issue":"7","key":"463_CR7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/arclin\/15.7.603","volume":"15","author":"M Moleski","year":"2000","unstructured":"Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol. 2000;15(7):603\u201330.","journal-title":"Arch Clin Neuropsychol"},{"issue":"14","key":"463_CR8","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1002\/cncr.25098","volume":"116","author":"JS Wefel","year":"2010","unstructured":"Wefel JS et al. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 2010;116(14):3348\u201356.","journal-title":"Cancer"},{"issue":"3","key":"463_CR9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/jnci\/90.3.210","volume":"90","author":"FS Dam van","year":"1998","unstructured":"van Dam FS et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst. 1998;90(3):210\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"463_CR10","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/jnci\/djj470","volume":"98","author":"SB Schagen","year":"2006","unstructured":"Schagen SB et al. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. J Natl Cancer Inst. 2006;98(23):1742\u20135.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"463_CR11","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1158\/1078-0432.CCR-11-2000","volume":"18","author":"LA Christie","year":"2012","unstructured":"Christie LA et al. Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy. Clin Cancer Res. 2012;18(7):1954\u201365.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"463_CR12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11065-008-9058-x","volume":"18","author":"JS Wefel","year":"2008","unstructured":"Wefel JS, Witgert ME, Meyers CA. Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Rev. 2008;18(2):121\u201331.","journal-title":"Neuropsychol Rev"},{"issue":"6","key":"463_CR13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1200\/JCO.2014.56.8345","volume":"33","author":"V Koppelmans","year":"2015","unstructured":"Koppelmans V et al. Prevalence of cerebral small-vessel disease in long-term breast cancer survivors exposed to both adjuvant radiotherapy and chemotherapy. J Clin Oncol. 2015;33(6):588\u201393.","journal-title":"J Clin Oncol"},{"issue":"3","key":"463_CR14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10549-006-9380-z","volume":"103","author":"DH Silverman","year":"2007","unstructured":"Silverman DH et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5\u201310 years after chemotherapy. Breast Cancer Res Treat. 2007;103(3):303\u201311.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"463_CR15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/cncr.22368","volume":"109","author":"M Inagaki","year":"2007","unstructured":"Inagaki M et al. Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer. 2007;109(1):146\u201356.","journal-title":"Cancer"},{"key":"463_CR16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1471-2407-6-240","volume":"6","author":"D Goldstein","year":"2006","unstructured":"Goldstein D et al. Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer. 2006;6:240.","journal-title":"BMC Cancer"},{"issue":"4","key":"463_CR17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0885-3924(99)00082-2","volume":"18","author":"PB Jacobsen","year":"1999","unstructured":"Jacobsen PB et al. Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manag. 1999;18(4):233\u201342.","journal-title":"J Pain Symptom Manag"},{"issue":"8","key":"463_CR18","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/cncr.22993","volume":"110","author":"PB Jacobsen","year":"2007","unstructured":"Jacobsen PB et al. Fatigue after treatment for early stage breast cancer: a controlled comparison. Cancer. 2007;110(8):1851\u20139.","journal-title":"Cancer"},{"issue":"5","key":"463_CR19","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1200\/JCO.1998.16.5.1689","volume":"16","author":"JA Broeckel","year":"1998","unstructured":"Broeckel JA et al. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol. 1998;16(5):1689\u201396.","journal-title":"J Clin Oncol"},{"key":"463_CR20","doi-asserted-by":"crossref","unstructured":"Birks J, Harvey RJ. Donepezil for dementia due to Alzheimer\u2019s disease. Cochrane Database Syst Rev. 2003;(3):Cd001190, Review.","DOI":"10.1002\/14651858.CD001190"},{"issue":"3","key":"463_CR21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1017\/S1461145704004444","volume":"7","author":"JG Evans","year":"2004","unstructured":"Evans JG, Wilcock G, Birks J. Evidence-based pharmacotherapy of Alzheimer's disease. Int J Neuropsychopharmacol. 2004;7(3):351\u201369.","journal-title":"Int J Neuropsychopharmacol"},{"key":"463_CR22","doi-asserted-by":"crossref","unstructured":"Malouf R, Birks J. Donepezil for vascular cognitive impairment. Cochrane Database Syst Rev. 2004;(1):Cd004395, Review.","DOI":"10.1002\/14651858.CD004395.pub2"},{"issue":"9","key":"463_CR23","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1212\/WNL.56.9.1133","volume":"56","author":"RC Petersen","year":"2001","unstructured":"Petersen RC et al. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1133\u201342.","journal-title":"Neurology"},{"issue":"4","key":"463_CR24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.wnf.0000138636.42121.45","volume":"27","author":"R Ceravolo","year":"2004","unstructured":"Ceravolo R et al. Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease. Clin Neuropharmacol. 2004;27(4):166\u201370.","journal-title":"Clin Neuropharmacol"},{"issue":"9","key":"463_CR25","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1200\/JCO.2005.03.3001","volume":"24","author":"EG Shaw","year":"2006","unstructured":"Shaw EG et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol. 2006;24(9):1415\u201320.","journal-title":"J Clin Oncol"},{"issue":"15","key":"463_CR26","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1200\/JCO.2014.58.4508","volume":"33","author":"SR Rapp","year":"2014","unstructured":"Rapp SR et al. Donepezil for irradiated brain tumor services: a phase III randomized, placebo-controlled clinical trial. J Clin Oncol. 2014;33(15):1653\u20139.","journal-title":"J Clin Oncol"},{"issue":"11","key":"463_CR27","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00520-006-0037-6","volume":"14","author":"J Vardy","year":"2006","unstructured":"Vardy J et al. Assessing cognitive function in cancer patients. Support Care Cancer. 2006;14(11):1111\u20138.","journal-title":"Support Care Cancer"},{"issue":"2","key":"463_CR28","first-page":"125","volume":"5","author":"J Brandt","year":"1991","unstructured":"Brandt J. The Hopkins of Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neurophysiol. 1991;5(2):125\u201342.","journal-title":"Clin Neurophysiol"},{"key":"463_CR29","unstructured":"Saxton J, Becker JT, Wisniewski SR. The ROCF and dementia. In: Knight JA, Kaplan E, editors. The handbook of Rey\u2013Osterrieth complex figure usage: clinical and research applications. Lutz, FL: Psychological Assessment Resources; 2003:659-82."},{"issue":"3","key":"463_CR30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","volume":"8","author":"RM Reitan","year":"1958","unstructured":"Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8(3):271\u20136.","journal-title":"Percept Mot Skills"},{"issue":"4","key":"463_CR31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/arclin\/11.4.329","volume":"11","author":"RM Ruff","year":"1996","unstructured":"Ruff RM et al. Benton Controlled Oral Word Association Test: reliability and updated norms. Arch Clin Neuropsychol. 1996;11(4):329\u201338.","journal-title":"Arch Clin Neuropsychol"},{"key":"463_CR32","unstructured":"Weschler D. Wechsler Adult Intelligence Scale-III (WAIS-III). New York: Psychological Corporation\/Harcourt, Inc; 1996."},{"key":"463_CR33","volume-title":"Instruction manual for the adult neuropsychological test battery","author":"CG Matthews","year":"1970","unstructured":"Matthews CG, Klove H. Instruction manual for the adult neuropsychological test battery. Madison: University of Wisconsin Medical School; 1970."},{"issue":"6","key":"463_CR34","first-page":"W32","volume":"7","author":"LI Wagner","year":"2009","unstructured":"Wagner LI et al. Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument. J Support Oncol. 2009;7(6):W32\u20139.","journal-title":"J Support Oncol"},{"issue":"8","key":"463_CR35","doi-asserted-by":"crossref","first-page":"904","DOI":"10.6004\/jnccn.2010.0067","volume":"8","author":"AM Berger","year":"2010","unstructured":"Berger AM et al. Cancer-related fatigue. J Natl Compr Cancer Netw. 2010;8(8):904\u201331.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"32","key":"463_CR36","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1200\/JCO.2007.11.7275","volume":"25","author":"LI Wagner","year":"2007","unstructured":"Wagner LI et al. Patient-reported outcomes in phase II cancer clinical trials: lessons learned and future directions. J Clin Oncol. 2007;25(32):5058\u201362.","journal-title":"J Clin Oncol"},{"issue":"2","key":"463_CR37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/cncr.10245","volume":"94","author":"D Cella","year":"2002","unstructured":"Cella D et al. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002;94(2):528\u201338.","journal-title":"Cancer"},{"issue":"5 Suppl 1","key":"463_CR38","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/01.mlr.0000250483.85507.04","volume":"45","author":"BB Reeve","year":"2007","unstructured":"Reeve BB et al. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care. 2007;45(5 Suppl 1):S22\u201331.","journal-title":"Med Care"},{"issue":"6","key":"463_CR39","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14(6):540\u20135.","journal-title":"Sleep"},{"issue":"5","key":"463_CR40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/NCC.0b013e3181a52533","volume":"32","author":"SL Beck","year":"2009","unstructured":"Beck SL et al. Symptom experiences and quality of life of rural and urban older adult cancer survivors. Cancer Nurs. 2009;32(5):359\u201369.","journal-title":"Cancer Nurs"},{"issue":"3","key":"463_CR41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hec.4730020305","volume":"2","author":"RD Hays","year":"1993","unstructured":"Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ. 1993;2(3):217\u201327.","journal-title":"Health Econ"},{"issue":"6","key":"463_CR42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00520-007-0341-9","volume":"16","author":"HG Mar Fan","year":"2008","unstructured":"Mar Fan HG et al. A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer. 2008;16(6):577\u201383.","journal-title":"Support Care Cancer"},{"issue":"12","key":"463_CR43","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/cncr.24287","volume":"115","author":"S Kohli","year":"2009","unstructured":"Kohli S et al. The effect of modafinil on cognitive function in breast cancer survivors. Cancer. 2009;115(12):2605\u201316.","journal-title":"Cancer"},{"issue":"13","key":"463_CR44","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1038\/npp.2013.172","volume":"38","author":"P Newhouse","year":"2013","unstructured":"Newhouse P et al. Tamoxifen improves cholinergically modulated cognitive performance in postmenopausal women. Neuropsychopharmacology. 2013;38(13):2632\u201343.","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"463_CR45","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1017\/S1355617714000125","volume":"20","author":"LJ Bernstein","year":"2014","unstructured":"Bernstein LJ, Catton PA, Tannock IF. Intra-individual variability in women with breast cancer. J Int Neuropsychol Soc. 2014;20(4):380\u201390.","journal-title":"J Int Neuropsychol Soc"},{"issue":"1","key":"463_CR46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejon.2006.02.005","volume":"11","author":"V Shilling","year":"2007","unstructured":"Shilling V, Jenkins V. Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs. 2007;11(1):6\u201315.","journal-title":"Eur J Oncol Nurs"},{"issue":"9","key":"463_CR47","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/annonc\/mdf241","volume":"13","author":"SB Schagen","year":"2002","unstructured":"Schagen SB et al. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol. 2002;13(9):1387\u201397.","journal-title":"Ann Oncol"},{"issue":"2","key":"463_CR48","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.breast.2004.10.004","volume":"14","author":"V Shilling","year":"2005","unstructured":"Shilling V et al. The effects of adjuvant chemotherapy on cognition in women with breast cancer\u2014preliminary results of an observational longitudinal study. Breast. 2005;14(2):142\u201350.","journal-title":"Breast"},{"issue":"2","key":"463_CR49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/13825585.2010.516814","volume":"18","author":"AL Gross","year":"2011","unstructured":"Gross AL et al. Word list memory predicts everyday function and problem-solving in the elderly: results from the ACTIVE cognitive intervention trial. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2011;18(2):129\u201346.","journal-title":"Neuropsychol Dev Cogn B Aging Neuropsychol Cogn"},{"issue":"2","key":"463_CR50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4048\/jbc.2013.16.2.229","volume":"16","author":"SY Hwang","year":"2013","unstructured":"Hwang SY, Chang SJ, Park BW. Does chemotherapy really affect the quality of life of women with breast cancer? J Breast Cancer. 2013;16(2):229\u201335.","journal-title":"J Breast Cancer"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-015-0463-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11764-015-0463-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-015-0463-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:49:36Z","timestamp":1559425776000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11764-015-0463-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["463"],"URL":"https:\/\/doi.org\/10.1007\/s11764-015-0463-x","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,1]]}}}